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In Brief
Interleukin-1b (IL-1b) is a major
inflammatory cytokine induced during
colitis, but how the microbiota regulate
this cytokine is largely unknown. Nunez
and colleagues show that IL-1b is
produced by recruited monocytes in
response to selective commensals to
promote colitis upon intestinal damage.
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The microbiota stimulates inflammation, but the sig-
naling pathways and the members of the microbiota
involved remain poorly understood. We found that
the microbiota induces interleukin-1b (IL-1b) release
upon intestinal injury and that this is mediated
via the NLRP3 inflammasome. Enterobacteriaceae
and in particular the pathobiont Proteus mirabilis,
induced robust IL-1b release that was comparable
to that induced by the pathogen Salmonella. Upon
epithelial injury, production of IL-1b in the intestine
was largely mediated by intestinal Ly6Chigh mono-
cytes, required chemokine receptor CCR2 and was
abolished by deletion of IL-1b in CCR2+ bloodmono-
cytes. Furthermore, colonization with P. mirabilis
promoted intestinal inflammation upon intestinal
injury via the production of hemolysin, which
required NLRP3 and IL-1 receptor signaling in vivo.
Thus, upon intestinal injury, selective members of
the microbiota stimulate newly recruited monocytes
to induce NLRP3-dependent IL-1b release, which
promotes inflammation in the intestine.
INTRODUCTION
The intestine is inhabited by trillions of resident bacteria that can
provide beneficial effects to the host (Kamada et al., 2013). For
example, bacterial metabolites including vitamins and short-
chain fatty acids contribute to appropriate development of the
host. Resident bacteria also confer resistance against pathogen
infection and are critically involved in the development of
lymphoid populations in the intestine (Kamada et al., 2013).
Because commensal bacteria can stimulate the immune system,
the host has evolved several mechanisms to prevent inappro-
priate activation of inflammatory responses in the intestine. For
instance, the intestinal epithelium and resident macrophages744 Immunity 42, 744–755, April 21, 2015 ª2015 Elsevier Inc.are hyporesponsive to bacterial Toll-like receptor ligands such
as lipopolysaccharides (Lotz et al., 2006; Smythies et al.,
2005). In addition, several barriers including the mucus layer
and antimicrobial peptides limit the contact between microbes
and the host immune system and contribute to gut homeostasis
(Kamada and Nu´n˜ez, 2014). A role for the microbiota in eliciting
intestinal inflammation is supported by findings that chemi-
cally-induced and spontaneous colitis are reduced or abolished
in antibiotic-treated mice and germ-free mice (Garrett et al.,
2007; Hudcovic et al., 2001; Kirkland et al., 2012; Kitajima
et al., 2001; Vijay-Kumar et al., 2007). In mouse models, certain
members of the microbiota have been linked to inflammatory re-
sponses and intestinal pathology. For example, Bacteroides
species andmembers of the Enterobacteriaceae family including
Klebsiella pneumoniae and Proteus mirabilis can promote colitis
(Bloom et al., 2011; Garrett et al., 2010). However, the signaling
pathways by which resident bacteria stimulate the host immune
system to induce inflammation in vivo remain poorly understood.
A critical step in the activation of inflammatory responses is
the recognition of microbes or endogenous molecules produced
in the setting of infection or cellular injury by host pattern-recog-
nition receptors (Takeuchi and Akira, 2010). A major innate
signaling pathway is the inflammasome, a multi-protein platform
that activates caspase-1 leading to the proteolytic processing of
pro-interleukin-1b (IL-1b) and pro-IL-18 into their mature active
forms (Schroder and Tschopp, 2010). To date, four bona fide
inflammasomes have been described, of which three, the
NLRP1, NLRP3 and NLRC4 inflammasomes, contain a member
of the intracellular Nod-like receptor (NLR) family (Franchi et al.,
2012b). Among the NLR inflammasomes, NLRP3 is activated by
multiple stimuli including bacterial pore-forming toxins, ATP,
microbial RNA, and particulate matter (Hornung et al., 2008;
Mariathasan et al., 2006). In contrast, NLRC4 activation is
induced by several Gram-negative pathogens by the transloca-
tion of small amounts of flagellin or PrgJ-like rod proteins into
the host cytosol (Franchi et al., 2006; Miao et al., 2010). In the
intestine, NLRC4-dependent IL-1b production is triggered by
Salmonella in resident phagocytes, which contribute to host
defense through the recruitment of neutrophils (Franchi et al.,
2012a). The role of the NLRP3 inflammasome in intestinal
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Figure 1. Commensal Bacteria Induce IL-1b
(A) Fecal contents (FC) obtained from GF or SPF
mice were used to stimulate BMDMs for 18 hr.
IL-1b was measured from culture supernatant
by ELISA.
(B) Total LP cells were isolated from PBS or anti-
biotic cocktail (ABX)-treated mice on day 7 after
mock or 2.5%DSS treatment and cultured for 3 hr.
IL-1b, IL-6, and TNF-a from culture supernatant
were measured by ELISA.
(C and D) GF and SPF mice were treated with 2%
DSS from day 0 to 6. Total LP cells were isolated
on day 7. (C) Total LP cells were cultured for 3 hr
and IL-1b was measured by ELISA. (D) pro-IL-1b
mRNA expression was analyzed by qRT-PCR and
normalized relative to GAPDH expression.
(A–D) Data are representative of at least two indi-
vidual experiments and values represent mean of
triplicate samples ± SD. **p < 0.01, ***p < 0.001.inflammation is controversial. For example, some studies
showed that mice lacking NLRP3 or caspase-1 were less sus-
ceptible to chemically-induced colitis (Bauer et al., 2012; Bauer
et al., 2010), whereas other authors reported increased suscep-
tibility and worsened pathology (Allen et al., 2010; Zaki et al.,
2010). The role of IL-1b in colitis is also controversial. Some
studies showed that blocking of IL-1b signaling ameliorate
intestinal inflammation in different animal colitis models (Coccia
et al., 2012; Saitoh et al., 2008), but one study showed that
IL-1b-deficient mice are more susceptible to experimental colitis
than wild-type (WT) mice (Bersudsky et al., 2014). The reasons
for these contradictory results are unclear, but it might be
caused, at least in part, by baseline differences in the gut micro-
biota (Bauer et al., 2012). While some intestinal commensals
such as Escherichia coli can induce IL-1b via the NLRP3 inflam-
masome in bone-marrow-derived macrophages (BMDMs), the
ability of resident bacteria to induce IL-1b in vivo and the innate
immune cells involved in IL-b release in response to the intestinal
microbiota remain unclear. In this study, we provide evidence
that selective members of the microbiota and specifically
P. mirabilis can induce robust IL-1b production via the NLRP3
inflammasome and promote IL-1b-dependent inflammation in
the intestine. Production of IL-1b by the microbiota is mediated
by CCR2+ monocytes that are recruited to the intestine in
response to epithelial injury.
RESULTS
Intestinal Resident Bacteria Induce IL-1b Release
and Promote Colitis via IL-1b
To determine whether the fecal microbiota induce IL-1b release,
BMDMswere stimulated with fecal contents from conventionally
reared mice and germ-free (GF) mice, and IL-1b was assessed
in the culture supernatants. The feces of conventionally raised
specific pathogen-free (SPF) mice, but not GF mice, induced
robust amounts of IL-1b (Figure 1A). To determine whether theImmunity 42, 744–7microbiota induces IL-1b in vivo, we
treated mice with a cocktail of antibiotics
or PBS and then orally with dextran sul-fate sodium (DSS), a chemical that damages the epithelium
resulting in exposure of lamina propia (LP) cells to luminal
microbes. Treatment with antibiotics reduced the production
of IL-1b, IL-6, and tumor necrosis factor alpha (TNF-a) by
LP cells when compared to PBS-treated mice (Figure 1B).
Consistently, LP cells from SPF mice produced more IL-1b
and pro-IL-1b mRNA than from GF mice after DSS administra-
tion (Figures 1C and 1D). To determine whether microbiota-
induced IL-1b is important for triggering intestinal inflammation
in vivo, we assessed features associated with inflammation
in WT and Il1b/ mice after DSS administration. IL-1b defi-
ciency was associated with reduced weight loss (Figure 2A)
and lower disease activity index (DAI) (Figure 2A). In addition,
WT mice had more colonic shortening, a marker of colitis
(Figure 2B), and exhibited more inflammation in the colon
upon DSS administration than Il1b/ mice (Figure 2C).
Depletion of the microbiota by treatment with antibiotics abol-
ished the phenotype associated with IL-1b deficiency (Figures
2D–2F). These results indicate that the microbiota induces
IL-1b upon epithelial damage and IL-1b promotes intestinal
inflammation.
Commensal Bacteria Induce IL-1b Release via
the NLRP3 Inflammasome
To begin to understand how the intestinal microbiota induces the
release of IL-1b, we stimulated BMDMs from WT and mice defi-
cient in caspase-1, the essential adaptor ASC and different
sensors that activate the inflammasome with fecal contents.
The production of IL-1b, but not TNF-a, required caspase-1,
NLRP3, or ASC (Figures 3A and 3B), but neither caspase-11
nor AIM2 or NLRC4 (Figures 3A and 3B). Consistently, cas-
pase-1 activation as determined by the formation of the mature
p20 subunit was induced by stimulation with fecal contents in
WT, but not Nlrp3/ macrophages (Figure 3C). To determine
whether the NLRP3 inflammasome is important for the induction
of IL-1b in vivo, we purified LP cells from DSS-treated WT mice55, April 21, 2015 ª2015 Elsevier Inc. 745
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Figure 2. IL-1b Induced by the Commensal
Bacteria Promotes Colitis
(A) WT and Il1b/ mice were treated with 2%
DSS from day 0 to day 6. Body weight and
disease activity index (DAI) were measured daily
for 2 weeks. Values represent means ± SEM.
(B and C) WT and Il1b/ mice were treated with
2% DSS from day 0 to day 6 and euthanized at
day 10. (B) Colon length was measured and (C)
pathology score were assessed.
(D)WT and Il1b/micewere treated with 2%DSS
from day 0 to day 6 and received PBS or ABX daily
by oral gavage from day 1 to 7. Body weight
and disease activity index (DAI) were measured
daily for 2 weeks. Values represent means ± SEM.
(E and F) WT and Il1b/ mice were treated with
2%DSS from day 0 to day 6 and and received PBS
or ABX daily by oral gavage from day1 to 7. Mice
were euthanized at day 10. (E) Colon length was
measured and (F) pathology score were assessed.
(C and F) Representative images of the distal
colon. Open arrowheads denote mucosal ulcer
with total loss of epithelium. Solid arrows indicate
presence of acute inflammatory cells and/or
edema in the submucosa. Scale bar represents
500 mm.
All data are pooled from two separate experiments
(n > 8, each group). *p < 0.05, **p < 0.01, ***p <
0.001.and mutant mice deficient in inflammasome components and
assessed the release of IL-1b by LP cells ex vivo. LP cells purified
from the colonic LP of WT mice released spontaneously IL-1b
and this response was impaired in Casp1/, Nlrp3/, and
Pycard/ mice (Figures 3D and 3E). These results indicate
that the microbiota induces IL-1b release via the NLRP3
inflammasome.
Recruited Monocytes Are the Major Source of IL-1b
Produced in Response to the Microbiota
The normal intestine contains large numbers of resident mono-
nuclear phagocytes including macrophages and dendritic cells.
In addition, blood monocytes are rapidly recruited to the intesti-
nal tissue in response to inflammatory stimuli (Zigmond and746 Immunity 42, 744–755, April 21, 2015 ª2015 Elsevier Inc.Jung, 2013). We determined next which
population of mononuclear phagocytic
cells produces IL-1b in response to the
microbiota. We purified LP cells from
naive mice and mice harboring CD11b+
Ly6Chigh inflammatory monocytes (IM)
in response to DSS administration. In
ex vivo experiments, intestinal phago-
cytic cells from DSS-treated mice, but
not naive mice, spontaneously produced
IL-1b, which was further enhanced by
the addition of ATP, a signal that activates
the NLRP3 inflammasome (Figure 4A). In
contrast, production of IL-6 was compa-
rable in naive and DSS-treated mice and
was not enhanced by ATP (Figure 4A).
Notably, resident LP cells from naiveanimals did not produce IL-1b even after addition of exogenous
ATP (Figure 4A). Production of IL-1b by LP phagocytes was de-
tected at day 3 and peaked around day 7 after DSS (Figure 4B).
The kinetics of IL-1b production by LP cells correlated with
the number of IM (CD11b+Ly6Chigh) recruited to the intestine
(Figures 4B and 4C). To define the LP populations that produce
IL-1b in response to the microbiota, we sorted LP cells from
DSS-treated mice into CD11b+Ly6Chigh (IMs), CD11b+Ly6Clow
(phagocytes), and CD11bLy6C (non-phagocytes). CD11b+
Ly6Chigh cells released more IL-1b and expressed higher
amounts of Nlrp3 mRNA than phagocytes and non-phagocytic
cells (Figure 4D). IMs isolated from the colon of DSS-treated
Nlrp3/ and Pycard/ mice released less IL-1b than WT,
Aim2/, and Nlrc4/ IMs (Figure 4E). The spontaneous release
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Figure 3. Commensal Bacteria Induce IL-1b
through the NLRP3 Inflammasome
(A and B) Fecal contents (FC) obtained from
SPF mice were used to stimulate WT, Casp11/,
Casp1/Casp11/ BMDMs (A) and WT,
Aim2/, Nlrc4/, Nlrp3/, Pycard/ BMDMs
(B) for 18 hr. IL-1b and TNF-awere measured from
culture supernatant.
(C) WT and Nlrp3/ BMDMs were stimulated with
FC obtained from SPF mice and caspase-1 was
detected by immunoblotting. Open arrow heads
indicate non-specific bands.
(D and E) WT, Casp11/, Casp1/Casp11/,
Nlrp3/, and Pycard/ mice were treated with
2.5% DSS from day 0 to 7. Total LP cells were
cultured for 3 hr and IL-1b and IL-6 weremeasured
in culture supernatant.
Values represent mean of triplicate samples ± SD.
Data are representative for three experiments.
*p < 0.05, **p < 0.01, ***p < 0.001.of IL-1b by CD11b+Ly6Chigh cells was largely triggered by the
microbiota because it was greatly reduced in cells isolated
from the intestine of DSS-treated GF mice (Figure 4F).
To further verify the role of recruited IM in microbiota-induced
IL-1b release, we used mice deficient in CCR2, which is an
essential chemokine receptor for emigration of Ly6Chigh mono-
cytes from the BM and recruitment to the intestine (Kim et al.,
2011; Serbina and Pamer, 2006). Ccr2/ mice exhibited
impaired recruitment of IM to the intestine in response to DSS
administration (Figure S1A). CCR2 deficiency abolished the
release of IL-1b by LP cells isolated from DSS-treated mice
(Figure 4G). Given that IMs can produce various different inflam-
matory mediators capable of activating surrounding cells and
contribute to develop DSS-induced colitis (Waddell et al.,
2011) (Figure S1B), we used CCR2-diphtheria toxin receptor
(Ccr2DTR/+) depleter mice to determine the autonomous role of
IMs in IL-1b production. We used Ccr2DTR/+ mice to generate
mixed chimeras by transplanting mixtures of BM from WT or
Il1b/ mice with BM from Ccr2DTR/+ mice at a 1:1 ratio into
lethally-irradiated WT mice. Consistent with previous results
(Hohl et al., 2009), we found efficient depletion (>90%) of
CCR2+ monocytes after a single intraperitoneal (i.p.) administra-
tion of DT to Ccr2DTR/+ mice (Figure S1C). LP cells from recipient
mice reconstituted with WT (Il1b+/+) andCcr2DTR/+ BM produced
comparable amounts of IL-1b after DSS treatment regardless
of DT treatment (Figure 4H). Consistent with mixed chimerism,
LP cells from mice reconstituted with Il1b/ and Ccr2DTR/+
BM released less IL-1b thanmice reconstituted withWTBM (Fig-
ure 4H). Notably, the release of IL-1b, but not TNF-a, by LP cells
frommice reconstituted with Il1b/ andCcr2DTR/+ bonemarrow
was abrogated after DT treatment (Figure 4H). Flow cytometricImmunity 42, 744–7analysis revealed comparable numbers
of CD11b+Ly6Chi IM in the LP of DT-
and DSS-treated Il1b+/++Ccr2DTR/+ and
Il1b/+Ccr2DTR/+ mice (Figure S1D),
ruling out that the impairment of IL-1b
release was caused by defective intesti-
nal recruitment of IM in Il1b/+Ccr2DTR/+chimeric mice. Collectively, these results indicate that IM re-
cruited to the intestine are the major source of IL-1b produced
in response to stimulation by the microbiota.
Selective Resident Bacteria Elicit Robust Release
of IL-1b
To identify commensal bacteria that induce IL-1b release, we
screened a panel of bacterial species isolated from the mouse
intestine for their ability to trigger IL-1b production in macro-
phages at a low bacteria-macrophage ratio. Because fecal con-
tents could induce IL-1b production under aerobic conditions,
we first tested aerobic or facultative anaerobic commensal
bacteria. All commensal bacteria tested could induce pro-IL-1b
mRNA expression (Figure 5A, top panel). Notably, P. mirabilis,
out of 13 tested, induced rapid and robust secretion of IL-1b
(Figure 5A, middle panel). We also assessed the ability of
Bacteroides and Clostridium species to induce IL-1b; however,
these abundant anaerobic bacteria did not induce IL-1b release
(data not shown). Remarkably, the kinetics and potency of
P. mirabilis to induce IL-1b release was comparable to that of
the pathogen Salmonella enterica Typhimurium (Figure 5A).
After longer stimulation (18 hr), the commensal E. coli and the
pathogen Citrobacter rodentium induced IL-1b secretion but in
lower amounts than P. mirabilis (Figure S2). The link between
P.mirabilis and IL-1bwas highly specific in that most commensal
bacteria triggered TNF-a (Figure 5A, lower panel, and Figure S2).
To test specificity of P. mirabilis to induce IL-1b production
in vivo, we mono-associated GF mice with P. mirabilis,
B. acidifaciens, C. sporogenes, or E. coli and monitored their
intestinal colonization in the feces before DSS treatment.
Despite comparable bacterial colonization (Figure S3), LP cells55, April 21, 2015 ª2015 Elsevier Inc. 747
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Figure 4. Recruited Inflammatory Mono-
cytes Are the Main Source of IL-1b during
DSS-Induced Colitis
(A) Total LP cells isolated on day 0 (naive) and on
day 7 (DSS) after DSS treatment were cultured for
3 hr and left unstimulated or cultured in the pres-
ence of 5 mM ATP for the additional 30 min. IL-1b
and IL-6 were measured from culture supernatant.
(B and C) Total LP cells were isolated at indicated
times from WT mice given 2.5% DSS from day
0 to day 7. (B) IL-1b was measured from culture
supernatant after 3 hr of culture. (C) Percent
of inflammatory monocytes (CD11b+Ly6Chigh) in
CD45+ LP cells was determined by flow cytometry.
Open circles represents means of values from
individual mice.
(D) Total LP cells were isolated from DSS-treated
mice on day 7 after 2.5%DSS treatment and CD45+
cells were sorted according to CD11b and Ly6C
expression. Sorted cells were cultured for 3 hr and
IL-1b in culture supernatant and Nlrp3 mRNA
expression was analyzed by ELISA and qRT-PCR,
respectively.
(E) WT, Aim2/,Nlrc4/, Nlrp3/, and Pycard/
micewere treatedwith 2.5%DSS for 7 days. Sorted
inflammatory monocytes were cultured for 3 hr
and IL-1b was measured in culture supernatant.
(F) GF and SPF mice were treated with 2% DSS
for 6 days. Sorted inflammatory monocytes (IM)
were cultured for 3 hr and IL-1b was measured in
culture supernatant.
(G) WT and Ccr2/ mice were treated with 2.5%
DSS for 7 days. Total LP cells were cultured for 3 hr
and IL-1b was measured in culture supernatant.
(H) IL-1b release by total LP cells isolated from
indicated chimera mice. Mice received PBS or DT
on day 0, 3, and 6. LP cells were isolated on day 7 and cultured for 3 hr to measure cytokine concentrations in culture supernatant.
Data are representative of at least two experiments. Values are means of triplicate samples ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S1.isolated from mice mono-associated with P. mirabilis produced
more IL-1b than LP cells from mice colonized with the other
commensal bacteria (Figure 5B). Analyses of macrophages
deficient in components of the inflammasome revealed that
IL-1b release and caspase-1 activation, but not TNF-a, induced
by P. mirabiliswas abolished in Nlrp3/ and Pycard/ BMDMs
(Figures 5C and 5D). Similarly, P. mirabilis induced IL-1b release
in LP cells isolated from DSS-treated WT mice after 3 hr culture,
and this response was largely dependent on caspase-1 and
NLRP3, but much less on caspase-11 (Figures 5E and 5F).
Consistent with previous results, P. mirabilis induced more IL-
1b release than E. coli in LP cells (Figure 5F). LP cells isolated
from Ccr2/ mice treated with DSS did not release IL-1b after
P. mirabilis stimulation (Figure 5G). To determine whether
P. mirabilis is sufficient to induce IL-1b production in vivo, we
colonized GF mice with P. mirabilis and assessed the sponta-
neous production of IL-1b by LP cells purified from untreated
and DSS-treated mice. Consistent with an important role for
recruited monocytes, there was no or minimal IL-1b release
by LP cells isolated from untreated mice colonized with
P. mirabilis or GF mice treated with DSS (Figure 5H). In contrast,
we found increased IL-1b production by LP cells from GF mice
colonized with P. mirabilis and treated with DSSwhen compared
to mice treated with the bacterium or DSS alone (Figure 5H).748 Immunity 42, 744–755, April 21, 2015 ª2015 Elsevier Inc.P. mirabilis HpmA Hemolysin Is Required for the
Activation of the NLRP3 Inflammasome
We sequenced the genome of the mouse P. mirabilis referred
here as strain UM001 to identify candidate genes that might
be involved in triggering NLRP3 activation. We obtained a
3,950,860 base-pair (bp)-long genomic sequence of the
P. mirabilis strain UM001 which revealed 3,579 putative pro-
tein-coding and 84 noncoding genes within 28 contigs (Fig-
ure S4A). Comprehensive comparison analysis of the genomic
sequences by RAST showed that the mouse P. mirabilis genome
contains several virulence genes that are also present in the
reference human P. mirabilis strain H14320 (Aziz et al., 2008;
Pearson et al., 2008). These genes included cheW (a regulator
of chemotaxis), fliF (flagellin), hpmA (hemolysin), mrpA (fimbria),
genes encoding essential proteins of a T3SS such as spa47, and
ureC (urease) (Figure S4B). Notably, the human P. mirabilis strain
HI4320 also induced IL-1b release (Figure 6A). Analyses of
several isogenic P. mirabilis mutants of HI4320 revealed that
hpmA, but not cheW, cpsF, fliF, mrpA, or ureC, was required
for the induction of IL-1b release, but not of TNF-a (Figure 6A).
Expression of the hpmA gene was detected in both the mouse
and human P. mirabilis strains (Figure S4C). Comparison of the
HpmA amino acid sequence from the mouse and human strains
revealed that they were 99% identical (Figure S4D). Secretion of
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Figure 5. Selective Commensals Induce IL-
1b Release through the NLRP3 Inflamma-
some
(A) BMDMs were stimulated with indicated mouse
commensal bacteria, Citrobacter rodentium (Cr),
or Salmonella enterica serovar Typhimurium (ST)
at a bacteria:macrophage ratio of 1. Abbreviations
are as follows: Ebc, Enterobacter cloacae; Ebh,
E. hormaechei; Ecc, Enterococcus casseliflavus;
Ecf, E. faecalis; Ecg, E. gallinarum; Ec, Escherichia
coli; Ko, Klebsiella oxytoca; Kp, K. pneumoniae;
Lm, Lactobacillus murinus; Lr, L. reuteri; Ss,
Staphylococcus sciuri; Sx, S. xylosus; Pm,
Proteus mirabilis. Levels of cytokines in culture
supernatant and pro-IL-1b mRNA expression at
3 hr were determined by ELISA and qRT-PCR,
respectively. Values represent means of triplicate
samples ± SD.
(B) GF mice were mono-associated with indicated
mouse commensal bacteria. Ba, Bacteroides
acidifaciens; Cs, Clostridium sporogenes; Ec,
E. coli; Pm, P. mirabilis. Mice were treated with 1%
DSS for 7 days and total LP cells were isolated and
cultured for 3 hr to assess IL-1b release in super-
natant. Means of values from one or two mice are
indicated. Results are pooled from three experi-
ments with similar results.
(C) WT, Nlrp3/, and Pycard/ BMDMs were
stimulated with mouse Pm and cytokines were
measured in culture supernatant after 3 hr. Values
represent means of triplicate samples ± SD.
(D) WT and Nlrp3/ BMDMs were stimulated with
Ec, Pm, and ST for 3 hr and caspase-1 activation
was detected by immunoblotting.
(E–G) WT or indicated mutant mice were treated
with 2.5% DSS for 7 days and total LP cells
were isolated and were stimulated with indicated
bacteria at a bacteria:macrophage ratio of 1
for 3 hr. Values represent means of triplicate
samples ± SD.
(H) GF mice or gnotobiotic mice monocolonized
with mouse P. mirabilis by oral gavage were
treated with 2% DSS for 6 days. Total LP cells
were isolated on day 7 and IL-1b was determined in culture supernatant after 3 hr. Values represent means of triplicate samples ± SD.
Data are representative of at least two experiments. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figures S2 and S3.IL-1b via the NLRP3 inflammasome requires signal 1 that in-
duces pro-IL-1b and signal 2 that activates caspase-1 (Franchi
et al., 2012b). To assess whether HpmA can provide signal 1
or signal 2, we stimulated BMDMs with DhpmA P. mirabilis or
LPS as an inducer of signal 1 in absence or presence of ATP
which provides signal 2 for inflammasome activation. Both
DhpmA P. mirabilis and LPS induced the release of IL-1b and
caspase-1 activation, but only in the presence of ATP (Figures
6B and 6C). Together with results shown in Figure 6A, the data
indicate that DhpmA P. mirabilis can only provide signal 1 and
that HpmA is required for P. mirabilis to provide signal 2 for acti-
vation of the NLRP3 inflammasome. Complementation of the
DhpmA mutant strain with a hpmA expression plasmid rescued
the ability of the mutant strain to induce IL-1b release, but it
did not affect its ability to release TNF-a (Figure 6D). K+ efflux
is a common event that is required for NLRP3 activation induced
bymultiple stimuli (Mun˜oz-Planillo et al., 2013). Consistently, WT
P. mirabilis, but not the DhpmA mutant, induced K+ efflux whichwas enhanced in the DhpmA mutant reconstituted with hpmA
plasmid (Figure 6E). The enhanced induction of IL-1b and K+
efflux by the complemented (DhpmA+hpmA) strain presumably
results from the higher copy number of the plasmid-derived
hpmA gene. Culture of macrophages in 45 mM K+ inhibited the
ability of P. mirabilis to induce caspase-1 activation and the
release of IL-1b, but not that of TNF-a (Figures 6F and 6G).
Collectively, these results indicate that activation of the NLRP3
inflammasome by P. mirabilis is mediated by the HpmA
hemolysin.
P. mirabilis Colonization Enhances DSS-Induced Colitis
via NLRP3-Mediated IL-1 Signaling
To determine whether P. mirabilis can affect DSS-induced
colitis, we generated a streptomycin-resistant P. mirabilis
(StrR Pm) strain by culturing the mouse P. mirabilis bacterium
with streptomycin. Like the parental P. mirabilis strain, StrR
Pm induced IL-1b release and exhibited swarming capacityImmunity 42, 744–755, April 21, 2015 ª2015 Elsevier Inc. 749
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Figure 6. P.mirabilisHpmAMediates NLRP3
Inflammasome Activation
(A) BMDMs were pre-incubated with LPS (100 ng/
ml) for 3 hr and then stimulated with P. mirabilis
HI4320 (WT) and indicated isogenicmutants for 3 hr
at bacteria:macrophage ratio of 1. Cytokines were
measured in culture supernatant after 3 hr culture.
(B and C) WT or Nlrp3/ BMDMs were pre-incu-
bated with DhpmA Pm or LPS (100 ng/ml) for 3 hr
and left unstimulated or cultured in the presence
of 5 mM ATP for additional 30 min. (B) IL-1b and
TNF-a were measured from culture supernatant
of WT BMDMs. (C) Caspase-1 activation was de-
tected by immunoblotting.
(D and E) LPS-treated BMDMswere incubated with
HpmA-deficient (DhpmA) P. mirabilis mutant, and
the same strain complemented with hpmA plasmid
(DhpmA+hpmA). Cytokines in culture supernatant
(D) and intracellular K+ concentrations (E) were
measured at different time points.
(F andG)WT andNlrp3/BMDMswere stimulated
with P. mirabilis (Pm) in culture medium containing
the indicated concentration of extracellular K+. (F)
Cytokine concentrations in culture supernatant
were determined by ELISA. (G) Active caspase-1 in
cell lysate and cell supernatant were detected by
immunoblotting.
Values are means of triplicate samples ± SD.
Data are representative of at least three experi-
ments. *p < 0.05, **p < 0.01, ***p < 0.001. See also
Figure S4.(Figure S5). When mice were treated with streptomycin and
infected with StrR Pm, colonization of the StrR Pm strain was
detected in the luminal contents of the ileum, cecum, and colon
(Figure S6A) and the feces (Figure S6B). Notably, mice colonized
with P. mirabilis did not display obvious signs of intestinal
inflammation including loss of body weight, soft stools, or intes-
tinal inflammation by histological examination (Figure S6C and
S6D and data not shown). However, mice colonized with
P.mirabilis exhibitedmore loss of bodyweight and colonic short-
ening than control mice after DSS administration (Figures 7A
and 7B). The colitis induced by DSS is typically restricted to
the distal colon in normal mice (Brown et al., 2007). Remarkably,
mice colonized with P. mirabilis exhibited marked inflammation
in the cecum upon DSS administration (Figures 7C and 7D).
Consistent with the results in Figure 4, enhancement of DSS-co-
litis induced by P. mirabilis colonization was not detected in
Ccr2/ mice (Figures S6E and S6F). Furthermore, the increase
in body weight loss, colonic shortening, and enhanced tissue
pathology associated with P. mirabilis colonization were not750 Immunity 42, 744–755, April 21, 2015 ª2015 Elsevier Inc.observed in Nlrp3/ mice (Figures 7E–
7G) and were reversed by treatment with
Anakinra, an antagonist of IL-1 receptor
signaling (Figures 7H–7J). In order to rule
out the possibility that enhanced colitis
merely reflect higher numbers of bacteria
in P. mirabilis colonized mice, we inocu-
lated mice with the same number of WT
or DhpmA P. mirabilis by gavage. Analysis
of fecal samples of WT and DhpmAP. mirabilis showed comparable intestinal colonization (Fig-
ure S7). Importantly, colonization with DhpmA P. mirabilis
resulted in less body weight loss and colonic shortening
compared to colonization with WT P. mirabilis (Figure S7).
Collectively, the results indicate P. mirabilis colonization en-
hances DSS-induced colitis via NLRP3-mediated IL-1 signaling
in inflammatory monocytes.
DISCUSSION
Previous studies showed that the microbiota can promote intes-
tinal inflammation and pathology in animal models (Hudcovic
et al., 2001; Kirkland et al., 2012; Kitajima et al., 2001). A major
inflammatory pathway induced in the intestine is that triggered
by IL-1b. Clinical studies have suggested that IL-1b is important
in disease because robust amounts of IL-1b are released by
colonic LP cells from inflammatory bowel disease patients,
which correlates with lesional disease activity (Ligumsky et al.,
1990). However, the role of the microbiota and the mechanism
A B C
D
E F G
H I J
Figure 7. P. mirabilis Enhances DSS-
Induced Inflammation via NLRP3 and IL-1R
Signaling
Streptomycin-treated WT or Nlrp3/ mice were
gavaged with 1 3 109 CFU of streptomycin-
resistant P. mirabilis (Pm) on day 0, 4, and 8. Colitis
was induced by administration of 1% DSS from
day 0 to day 10.Mice were euthanized for analyses
on day 15.
(A–C) WT mice injected with PBS (n = 12) or
inoculated with Pm (n = 15).
(D) Representative histology of cecum and distal
colon in WT mice in the absence and presence
of Pm colonization after 1% DSS administration
on day 15 after DSS administration. Open arrow-
heads denote damaged or ulcerated mucosa with
total loss of epithelium, solid arrowheads indicate
presence of inflammatory cells in the submucosa
and edema. Scale bar represents 500 mm.
(E–G) Nlrp3/ mice injected with PBS (n = 12) or
inoculated with Pm (n = 11).
(H–J) Pm-colonized WT mice were injected daily
with PBS (n = 9) or Anakinra (Ana, 50 mg/kg, n = 8)
from day 4.
Body weight data were pooled from three
(A and E) or two (H) separate experiments.
Values represent means ± SEM. Colon length
and pathology score were pooled from two
experiments with similar results. *p < 0.05, **p <
0.01, ***p < 0.001, ns; not significant. See also
Figures S5–S7.involved in triggering IL-1b production are unclear. On the basis
of experiments in mice treated with antibiotics and GF mice, we
show that the microbiota is critical for the induction of IL-1b
release and this response is mediated by the NLRP3 inflam-
masome in vitro and in vivo. Remarkably, the great majority of
the resident bacteria isolated from the mouse intestine induce
little or no release of IL-1b, although they can elicit robust pro-
duction of TNF-a. Although several intestinal bacteria including
P. mirabilis and E. coli induce activation of the NLRP3 inflamma-
some in vitro, the ability of P. mirabilis to induce caspase-1 acti-
vation and IL-1b release was striking in that it was comparable to
that of pathogenic Salmonella. P. mirabilis was found to induce
robust IL-1b release; however, our results suggest that other
bacteria including E. coli can induce IL-1b in vitro and possibly
in vivo. Furthermore, commensals other than P. mirabilis, some
of which might be uncultivable, could be involved in regulating
IL-1b release in vivo. Although it is a member of the intestinal
microbiota in humans and mice (Armbruster and Mobley, 2012;
Garrett et al., 2010), P. mirabilis is a major cause of urinary
tract infection in humans (Armbruster and Mobley, 2012).Immunity 42, 744–7In the mouse model, P. mirabilis has
been linked to the severity of colitis (Gar-
rett et al., 2010). Thus, P. mirabilis acts
as a pathobiont in mice and humans.
Consistently, sequence analysis of the
mouse P. mirabilis genome revealed that
the commensal bacterium harbors multi-
ple virulence genes shared with human
uropathogenic P. mirabilis strains (Pear-son et al., 2008). One of the virulence genes, hpmA, was found
to be critical for the activation of NLRP3 inflammasome. The
hpmA gene encodes a secreted pore-forming cytolysin that is
produced during bacterial growth and infection (Swihart and
Welch, 1990). Although the function of HpmA in P. mirabilis is
unknown, our study indicates that HpmA can induce K+ efflux,
and this activity is sensed by host macrophages to activate the
NLRP3 inflammasome.
Several studies have assessed the role of the NLRP3 inflam-
masome in DSS-induced colitis with discordant results.
For example, two studies reported increased susceptibility to
DSS-induced colitis in Nlrp3/ mice, which was associated
with decreased IL-1b and IL-18 production, loss of epithelial
integrity, and increased colonic inflammation (Allen et al., 2010;
Zaki et al., 2010). In contrast, another group found lower concen-
trations of several cytokines including IL-1b in colonic tissue and
protection against colitis in Nlrp3/ mice (Bauer et al., 2010).
These contradictory results are paralleled by observations in
Casp1/ mice. For example, one study showed protection
against DSS-induced colitis in Casp1/ mice, whereas another55, April 21, 2015 ª2015 Elsevier Inc. 751
groups showed the opposite (Allen et al., 2010; Siegmund et al.,
2001; Zaki et al., 2010). Although it is difficult to ascertain the
reason for these contradictory results, recent studies showed
that protection of Nlrp3/ mice against colitis can be reversed
by co-housing Nlrp3/ mice with WT mice (Bauer et al.,
2012). The latter results suggest that the differences in results
regarding the role of the NLRP3 inflammasome might be ex-
plained, at least in part, by baseline differences in the intestinal
microbiota among mouse colonies. Given the marked variation
in the ability of different intestinal bacteria to activate the
NLRP3 inflammasome, it is likely that mice with different
microbiota composition will differ in the intestinal activation of
the inflammasome induced upon epithelial injury.
Intestinal bacteria belonging to the Enterobacteriaceae family
have been linked to colitis in mice and humans. For example,
P. mirabilis acts in concert with other intestinal bacteria to induce
colitis in TRUC mice, a spontaneous model of ulcerative colitis
(Garrett et al., 2010). Although themechanism that is responsible
for TRUC colitis is not fully understood, recent studies have
revealed an important role for group 3 innate lymphoid cells
(ILC3s) in the TRUC colitogenic phenotype (Powell et al.,
2012). Because the activation of ILC3s is induced via IL-23 and
IL-1b (Coccia et al., 2012; Takatori et al., 2009), it is possible
that P. mirabilis contributes to TRUC colitis through the acti-
vation of ILC3s and induction of colitogenic cytokines such as
IL-17A. Although there is no evidence as yet thatP.mirabilis con-
tributes to colitis in humans, adherent and invasive E. coli (AIEC)
strains that accumulate in the intestine of patients with inflamma-
tory bowel disease induce robust IL-1b release via the NLRP3
inflammasome (De la Fuente et al., 2014). Like P. mirabilis,
AIEC is a pathobiont that expresses virulence factors and can
enhance experimental colitis in mice (Drouet et al., 2012),
although the host signaling pathways involved remain unclear.
Because P. mirabilis colonization can promote colonic inflam-
mation via NLRP3, we suggest that Enterobacteriaceae family
members such as P. mirabilis and AIEC promote intestinal
inflammation, at least in part, by inducing local IL-1b release.
Colonization of conventionally reared mice or GF mice with
P. mirabilis alone did not cause overt colitis. The latter can be ex-
plained by the requirement of intestinal injury and recruitment
of inflammatory monocytes for the activation of the NLRP3 in-
flammasome and release of IL-1b. It is possible that the HpmA
is produced by P. mirabilis under steady-state conditions but
its activity is antagonized by host factors such as intraluminal
immunoglobulin A (IgA). Unlike resident mononuclear phago-
cytes that are hyporesponsive to commensal bacteria, inflam-
matory monocytes recruited to the intestine express NLRP3
and pro-IL-1b in response to microbial stimulation and are
responsive to NLRP3-activating signals such as ATP. Consistent
with these studies, Ly6Chigh inflammatory monocytes recruited
to the intestine in response to DSS express pattern-recognition
receptors such as TLR2 and NOD2 that sense bacteria and their
deletion attenuates DSS-induced colitis (Zigmond et al., 2012).
The lack of a functional NLRP3 inflammasome in resident
phagocytes might ensure that inappropriate production of
IL-1b is not induced under steady-state conditions or when
there is minimal epithelial injury. In contrast, resident intestinal
macrophages constitutively express NLRC4 and pro-IL-1b
and release IL-1b upon infection with enteric pathogens such752 Immunity 42, 744–755, April 21, 2015 ª2015 Elsevier Inc.as Salmonella (Franchi et al., 2012a). These observations
suggest that the NLRC4 inflammasome functions to detect
pathogen invasion early, whereas the NLRP3 inflammasome is
activated at later stages in inflammatory monocytes and might
serve to boost immune responses against invasive pathogens
and/or to enhance tissue repair in the intestine.
EXPERIMENTAL PROCEDURES
Mice
Six- to eight-week-old WT C57BL/6 (B6), Aim2/, Pycard/, Casp1/
Casp11/, Casp11/, Ccr2/, Il1b/, Nlrc4/, and Nlrp3/ mice in B6
background were bred and kept under specific pathogen-free (SPF) condi-
tions in University of Michigan Cancer Center. CCR2 depleter (Ccr2DTR/+)
mice were kindly provided by Dr. Eric Pamer, Memorial Sloan Kettering
Cancer Center (Hohl et al., 2009). GF mice were bred and maintained at
the GF Animal Core Facility of the University of Michigan. The animal studies
were conducted under protocols approved by the University of Michigan
Committee on Use and Care of Animals.
Bacteria
Commensal bacteria were isolated from the fecal content of B6mice. For most
commensals, the feceswere suspended in PBS, plated on Brain Heart Infusion
(BHI) plates at different dilutions under aerobic conditions, and individual
colonies isolated and frozen in glycerol. Lactobacillus spp. were plated on
de Man, Rogosa, and Sharpe (MRS) agar. For isolation of Bacteroides or
Clostridia species, fecal samples were plated on Bacteroides Agar, and BHI
agar plates containing 5% sheep blood, respectively, under anaerobic condi-
tions. The bacterial species were verified by 16S rRNA sequencing. Most of
bacteria were inoculated in Luria-Bertani (LB) broth (MP Biomedicals) and
cultured overnight at 37C with shaking. Lactobacillus spp. were inoculated
in MRS broth (Difco) and cultured for 2 days under anaerobic conditions.
Bacteroides and Clostridium were cultured in Chopped Meat Medium
(Anaerobe Systems) for 2 days under anaerobic conditions. To generate strep-
tomycin-resistant mouse-isolated P. mirabilis, we cultured multiple cycles of
bacteria in broth containing increasing doses of streptomycin (Calbiochem).
A single colony was picked from culture every two to three cycles using LB
plates containing tetracycline (20 mg/ml) and streptomycin (5 to 200 mg/ml).
P. mirabilis HI4320, a human urinary tract isolate has been described (Jones
and Mobley, 1987). Isogenic P. mirabilis HI4320 mutants constructed using
a TargeTron mutagenesis kit have been described (Alteri et al., 2013). To
generate hpmA-complemented human P. mirabilis HI4320 strain (HI4320
DhpmA+pGENhpmA), we transformed the mutant HI4320 DhpmA strain with
pGEN plasmid expressing hpmA and the bacteria selected with ampicillin
(20 mg/ml).
Genomic Sequencing Analysis
Whole-genome sequencing of P. mirabilis UM001 was performed on the
Illumina HiSeq 2000 platform using paired-end reads with 200–300 bp insert
size and 100 bp read length. Assembly of the 5.25 million reads obtained
was carried out using Velvet Optimizer (Zerbino and Birney, 2008) to produce
a final genome assembly 3,950,860 bp in length composed of 28 contigswith a
contig N50 of 377,567 bp. Annotation to identify coding sequences, assign
predicted functions, and to predict RNA structures was generated using
Prokka (Seemann, 2014).
DSS-Induced Colitis and P. mirabilis Colonization
Water containing 1%–2.5% DSS (molecular weight, 36,000–50,000; MP
Biomedicals) was administered for 6–10 days and the mice were switched
to regular water. Body weight and stool consistency were checked daily. In
some experiments, mice were given an antibiotic cocktail (500 mg of ampicillin,
250 mg of vancomycin, 250 mg of metronidazole, 250 mg of gentamycin, and
500 mg of neomycin) by gavage for 9 days starting 1 day prior to DSS
treatment. For P. mirabilis colonization experiments, mice received 2 g/L
streptomycin in the drinking water throughout the experiment starting
10 days before bacterial gavage. Mice were inoculated with 1 3 109 CFU of
streptomycin-resistant P. mirabilis by gavage and all mouse groups received
water containing 1%DSS for 10 days to induce colitis. To antagonize IL-1b, we
intraperitoneally injectedmice with Anakinra (50 mg/kg) daily from day 4 to day
14. Body weight measured every day and results are pool from 2 to 4 separate
experiments, which used at least three mice per group. Disease activity index
(DAI) was monitored every day in DSS-treated mice as described (Kamada
et al., 2005). Briefly, loss of body weight (0, none; 1, 1%–5%; 2, 5%–10%; 3,
10%–20%; 4, >20%), stool consistency (0, normal stool; 2, loose stool; 4,
diarrhea), hemoccult (0, normal; 2, homoccult positive; 4, gross blood). PBS-
injected and P. mirabilis-infected mice were sacrificed on day 15 and histolog-
ical score was evaluated blindly by one pathologist using a described scoring
system (Chen et al., 2008). Briefly, severity of inflammation (0, none; 1, mild; 2,
moderate; 3, severe), the level of involvement (0, none; 1, mucosa, 2; mucosa
and submucosa; 3, transmural), and extent of epithelial/crypt damage
(0, none; 1, basal 1/3; 2, basal 2/3; 3, crypt loss; 4, crypt and surface epithelial
destruction). Each variable was then multiplied by a factor reflecting the
percentage of the colon involved (0%–25%, 26%–50%, 51%–75%, 76%–
100%), and then summed to obtain the overall score.
Preparation and Culture of Macrophage and Intestinal Phagocytes
BMDMs and LP cells were prepared as described (Franchi et al., 2012a).
BMDMs (2 3 105 cells/well) were suspended in IMDM supplemented with
2% FBS and seeded in 48-multiwell plates. In some experiments, BMDMs
were stimulated with Ultrapure E. coli LPS (100 ng/ml; Invivogen) for 3 hr.
Feces from SPF or GF mice were suspended in sterile PBS (100 mg/ml),
homogenized, and spun at 1,000 rpm for 5 s. Fecal contents were passed
through 40 mm cell strainer (BD Falcon) to remove aggregates and used to
stimulate BMDMs at a 1:200 dilution. BMDMs were incubated with fecal
contents for 3 hr, the medium was replaced with fresh medium containing
gentamicin (100 mg/ml) and the culture continued for an additional 15 hr.
BMDMs were cultured with individual bacteria strains at a bacterial:
macrophage ratio of 1 for 3 hr. For long-term stimulation, the medium was
replaced with fresh medium containing gentamicin (100 mg/ml) and the
culture continued for an additional 15 hr. Isolated LP cells were resuspended
in RPMI medium containing 10% heat-inactivated fetal bovine serum (FBS),
2-b-mercaptoethanol (50 mM), L-glutamine (2 mM), sodium pyruvate (1 mM),
MEM non-essential amino acids (GIBCO). LP cells were pooled from two or
three mice per group, and total LP cells (2 3 105 cells/well) or sorted
cells (1 3 105 cells/well) were seeded in 96-multiwell plates in triplicate.
Cells were incubated for 3 hr in 5% CO2 incubator and cell-free supernatant
were subjected to further analysis. For ex vivo stimulation, cells were left
unstimulated or incubated with 5 mM ATP for 30 min or with bacteria at
bacteria:macrophage ratio of 1 for 3 hr.
Immunoblotting
Cells were lysed in buffer containing 1% NP-40 supplemented with complete
protease inhibitor cocktail (Roche) and 2 mM dithiothreitol. Lysates were
resolved by SDS-PAGE and transferred to PVDF membranes by electro-blot-
ting. The rabbit anti mouse caspase-1 antibody has been described (Franchi
et al., 2012a). Protein bands were revealed with goat anti-rabbit IgG antibody
(Jackson ImmunoResearch Laboratories) and enhanced chemiluminescent
substrate (Thermo Scientific).
Intracellular K+ Determination and Cytokine Detection
Intracellular K+ concentrations were measured as described previously
(Mun˜oz-Planillo et al., 2013). Mouse cytokines were measured in culture
supernatants by enzyme-linked immunosorbent assay (ELISA) kits (R&D
Systems).
Flow Cytometry and Cell Sorting
LP cells were stained with the following antibodies: CD45 (30-F11), CD11b
(M1/70), Ly6C (AL-21), Ly6G (1A8), all purchased from BD Pharmingen. Cells
were stained and sorted using a FACSAria III instrument (BD Bioscience).
Data were analyzed using FlowJo program (Tree Star).
Quantitative Real-Time PCR
RNA was extracted with E.Z.N.A. Total RNA Kit (Omega Biotek) according to
the manufacturer’s instructions. RNA was reverse transcribed using the High
Capacity RNA-to-cDNA Kit (Applied Biosystems) and cDNA was then usedfor quantitative PCR analysis using SYBR Green Gene-Expression Assay on
an ABI 7900HT analyzer. The following primer sets were used for amplification:
IL-1b-F; 50-GATCCACACTCTCCAGCTGCA, IL-1b-R; 50- CAACCAACAAGT
GATATTCTCCATG, NLRP3-F; 50-ATGGTATGCCAGGAGGACAG, NLRP3-R;
50-ATGCTCCTTGACCAGTTGGA, GAPDH-F; 50-TGCGACTTCAACAGCAAC
TC, GAPDH-R; 50-GCCTCTCTTGCTCAGTGTCC. Samples were run in tripli-
cate for each experimental condition and mean values were used to calculate
statistics.
Generation of Mixed Chimeric Mice
BM cells were obtained fromCcr2DTR/+ mice, mixed with equivalent number of
WT or Il1b/ BM cells and 1 3 107 donor cells were injected into 8-week-old
recipient WTmice that were lethally irradiated with 1,100 rads. Mice were used
8 weeks after reconstitution. To deplete CCR2+ cells, we intraperitoneally in-
jected 10 mg/kg diphtheria toxin (DT) on days 0, 3, 6.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism program (GraphPad
Software). Differences between two groups were evaluated using Student’s
t test. For multiple comparison, one-way ANOVA or Kruscal-Wallis test was
used. For body weight and DAI comparisons, two-way ANOVAwith Bonferroni
posttest was used. p < 0.05 was considered significant.
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